Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148


T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis.

Ramien C, Yusko EC, Engler JB, Gamradt S, Patas K, Schweingruber N, Willing A, Rosenkranz SC, Diemert A, Harrison A, Vignali M, Sanders C, Robins HS, Tolosa E, Heesen C, Arck PC, Scheffold A, Chan K, Emerson RO, Friese MA, Gold SM.

Cell Rep. 2019 Oct 22;29(4):810-815.e4. doi: 10.1016/j.celrep.2019.09.025.


Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats.

Das M, Mayilsamy K, Tang X, Han JY, Foran E, Willing AE, Mohapatra SS, Mohapatra S.

Sci Rep. 2019 Sep 20;9(1):13646. doi: 10.1038/s41598-019-49428-y.


Brazilian Jiu Jitsu Training for US Service Members and Veterans with Symptoms of PTSD.

Willing AE, Girling SA, Deichert R, Wood-Deichert R, Gonzalez J, Hernandez D, Foran E, Sanberg PR, Kip KE.

Mil Med. 2019 Apr 20. pii: usz074. doi: 10.1093/milmed/usz074. [Epub ahead of print]


Sex differences in autoimmune disorders of the central nervous system.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA.

Semin Immunopathol. 2019 Mar;41(2):177-188. doi: 10.1007/s00281-018-0723-8. Epub 2018 Oct 25.


Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.

Stoessel D, Stellmann JP, Willing A, Behrens B, Rosenkranz SC, Hodecker SC, Stürner KH, Reinhardt S, Fleischer S, Deuschle C, Maetzler W, Berg D, Heesen C, Walther D, Schauer N, Friese MA, Pless O.

Front Hum Neurosci. 2018 Jun 4;12:226. doi: 10.3389/fnhum.2018.00226. eCollection 2018.


Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients.

Delic V, Kurien C, Cruz J, Zivkovic S, Barretta J, Thomson A, Hennessey D, Joseph J, Ehrhart J, Willing AE, Bradshaw P, Garbuzova-Davis S.

J Neurosci Res. 2018 Aug;96(8):1353-1366. doi: 10.1002/jnr.24249. Epub 2018 May 6.


MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B.

J Neuroinflammation. 2018 Mar 19;15(1):88. doi: 10.1186/s12974-018-1108-6. Review.


T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder.

Patas K, Willing A, Demiralay C, Engler JB, Lupu A, Ramien C, Schäfer T, Gach C, Stumm L, Chan K, Vignali M, Arck PC, Friese MA, Pless O, Wiedemann K, Agorastos A, Gold SM.

Front Immunol. 2018 Feb 20;9:291. doi: 10.3389/fimmu.2018.00291. eCollection 2018.


Enhancing endogenous capacity to repair a stroke-damaged brain: An evolving field for stroke research.

Zhao LR, Willing A.

Prog Neurobiol. 2018 Apr - May;163-164:5-26. doi: 10.1016/j.pneurobio.2018.01.004. Epub 2018 Feb 21. Review.


Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor Expression.

Willing A, Jäger J, Reinhardt S, Kursawe N, Friese MA.

J Immunol. 2018 Feb 1;200(3):974-982. doi: 10.4049/jimmunol.1701213. Epub 2018 Jan 3.


Arc/Arg3.1 governs inflammatory dendritic cell migration from the skin and thereby controls T cell activation.

Ufer F, Vargas P, Engler JB, Tintelnot J, Schattling B, Winkler H, Bauer S, Kursawe N, Willing A, Keminer O, Ohana O, Salinas-Riester G, Pless O, Kuhl D, Friese MA.

Sci Immunol. 2016 Sep 23;1(3):eaaf8665. doi: 10.1126/sciimmunol.aaf8665.


Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.

Piédavent-Salomon M, Willing A, Engler JB, Steinbach K, Bauer S, Eggert B, Ufer F, Kursawe N, Wehrmann S, Jäger J, Reinhardt S, Friese MA.

Brain. 2015 Nov;138(Pt 11):3263-74. doi: 10.1093/brain/awv256. Epub 2015 Sep 10.


Repeated administrations of human umbilical cord blood cells improve disease outcomes in a mouse model of Sanfilippo syndrome type III B.

Willing AE, Garbuzova-Davis SN, Zayko O, Derasari HM, Rawls AE, James CR, Mervis RF, Sanberg CD, Kuzmin-Nichols N, Sanberg PR.

Cell Transplant. 2014;23(12):1613-30. doi: 10.3727/096368914X676916.


Human umbilical cord blood cells induce neuroprotective change in gene expression profile in neurons after ischemia through activation of Akt pathway.

Shahaduzzaman MD, Mehta V, Golden JE, Rowe DD, Green S, Tadinada R, Foran EA, Sanberg PR, Pennypacker KR, Willing AE.

Cell Transplant. 2015;24(4):721-35. doi: 10.3727/096368914X685311. Epub 2015 Feb 26.


Pro-inflammatory interferon gamma signaling is directly associated with stroke induced neurodegeneration.

Seifert HA, Collier LA, Chapman CB, Benkovic SA, Willing AE, Pennypacker KR.

J Neuroimmune Pharmacol. 2014 Dec;9(5):679-89. doi: 10.1007/s11481-014-9560-2. Epub 2014 Aug 8.


CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis.

Willing A, Leach OA, Ufer F, Attfield KE, Steinbach K, Kursawe N, Piedavent M, Friese MA.

Eur J Immunol. 2014 Oct;44(10):3119-28. doi: 10.1002/eji.201344160. Epub 2014 Aug 19.


Leukemia inhibitor factor promotes functional recovery and oligodendrocyte survival in rat models of focal ischemia.

Rowe DD, Collier LA, Seifert HA, Chapman CB, Leonardo CC, Willing AE, Pennypacker KR.

Eur J Neurosci. 2014 Oct;40(7):3111-9. doi: 10.1111/ejn.12675. Epub 2014 Jul 16.


Monocytes are essential for the neuroprotective effect of human cord blood cells following middle cerebral artery occlusion in rat.

Womble TA, Green S, Shahaduzzaman M, Grieco J, Sanberg PR, Pennypacker KR, Willing AE.

Mol Cell Neurosci. 2014 Mar;59:76-84. doi: 10.1016/j.mcn.2014.01.004. Epub 2014 Jan 25.


Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes.

Katnik C, Garcia A, Behensky AA, Yasny IE, Shuster AM, Seredenin SB, Petrov AV, Seifu S, McAleer J, Willing A, Cuevas J.

Neurobiol Dis. 2014 Feb;62:354-64. doi: 10.1016/j.nbd.2013.10.011. Epub 2013 Oct 16.


Human umbilical cord blood cells alter blood and spleen cell populations after stroke.

Golden JE, Shahaduzzaman M, Wabnitz A, Green S, Womble TA, Sanberg PR, Pennypacker KR, Willing AE.

Transl Stroke Res. 2012 Dec;3(4):491-9. doi: 10.1007/s12975-012-0208-3. Epub 2012 Sep 4.


A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus.

Shahaduzzaman M, Golden JE, Green S, Gronda AE, Adrien E, Ahmed A, Sanberg PR, Bickford PC, Gemma C, Willing AE.

Age (Dordr). 2013 Dec;35(6):2071-87. doi: 10.1007/s11357-012-9496-5. Epub 2012 Dec 22.


A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation.

Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, Pennypacker KR.

J Neuroimmune Pharmacol. 2012 Dec;7(4):1017-24. doi: 10.1007/s11481-012-9406-8. Epub 2012 Oct 6.


Neurovascular aspects of amyotrophic lateral sclerosis.

Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, Sanberg PR, Voltarelli JC, Garbuzova-Davis S.

Int Rev Neurobiol. 2012;102:91-106. doi: 10.1016/B978-0-12-386986-9.00004-1. Review.


CD8-mediated inflammatory central nervous system disorders.

Willing A, Friese MA.

Curr Opin Neurol. 2012 Jun;25(3):316-21. doi: 10.1097/WCO.0b013e328352ea8b. Review.


The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling.

Seifert HA, Leonardo CC, Hall AA, Rowe DD, Collier LA, Benkovic SA, Willing AE, Pennypacker KR.

Metab Brain Dis. 2012 Jun;27(2):131-41. doi: 10.1007/s11011-012-9283-0. Epub 2012 Feb 22.


Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction.

Rowe DD, Leonardo CC, Recio JA, Collier LA, Willing AE, Pennypacker KR.

J Biol Chem. 2012 Feb 3;287(6):4177-87. doi: 10.1074/jbc.M111.296434. Epub 2011 Dec 12.


Amyotrophic lateral sclerosis: a neurovascular disease.

Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, Sanberg PR.

Brain Res. 2011 Jun 29;1398:113-25. doi: 10.1016/j.brainres.2011.04.049. Epub 2011 May 12. Review.


Human Umbilical Cord Blood Cells Have Trophic Effects on Young and Aging Hippocampal Neurons in Vitro.

Chen N, Newcomb J, Garbuzova-Davis S, Davis Sanberg C, Sanberg PR, Willing AE.

Aging Dis. 2010 Dec 1;1(3):173-190.


The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells.

Sanberg PR, Eve DJ, Willing AE, Garbuzova-Davis S, Tan J, Sanberg CD, Allickson JG, Cruz LE, Borlongan CV.

Cell Transplant. 2011;20(1):85-94. doi: 10.3727/096368910X532855. Epub 2010 Sep 30. Review.


Cord blood administration induces oligodendrocyte survival through alterations in gene expression.

Rowe DD, Leonardo CC, Hall AA, Shahaduzzaman MD, Collier LA, Willing AE, Pennypacker KR.

Brain Res. 2010 Dec 17;1366:172-88. doi: 10.1016/j.brainres.2010.09.078. Epub 2010 Sep 29.


The effect of human umbilical cord blood cells on survival and cytokine production by post-ischemic astrocytes in vitro.

Jiang L, Saporta S, Chen N, Sanberg CD, Sanberg P, Willing A.

Stem Cell Rev Rep. 2010 Dec;6(4):523-31. doi: 10.1007/s12015-010-9174-x.


Administration of a Sigma Receptor Agonist Delays MCAO-Induced Neurodegeneration and White Matter Injury.

Leonardo CC, Hall AA, Collier LA, Green SM, Willing AE, Pennypacker KR.

Transl Stroke Res. 2010 Jun;1(2):135-45. doi: 10.1007/s12975-009-0005-9.


A new concept for the environmental risk assessment of poorly water soluble compounds and its application to consumer products.

Tolls J, Müller M, Willing A, Steber J.

Integr Environ Assess Manag. 2009 Jul;5(3):374-8.


Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b-expressing, isolectin-binding proinflammatory cells after middle cerebral artery occlusion.

Leonardo CC, Hall AA, Collier LA, Ajmo CT Jr, Willing AE, Pennypacker KR.

J Neurosci Res. 2010 May 1;88(6):1213-22. doi: 10.1002/jnr.22306.


Human umbilical cord blood cells decrease microglial survival in vitro.

Jiang L, Womble T, Saporta S, Chen N, Sanberg CD, Sanberg PR, Willing AE.

Stem Cells Dev. 2010 Feb;19(2):221-8. doi: 10.1089/scd.2009.0170.


Monocyte transplantation for neural and cardiovascular ischemia repair.

Sanberg PR, Park DH, Kuzmin-Nichols N, Cruz E, Hossne NA Jr, Buffolo E, Willing AE.

J Cell Mol Med. 2010 Mar;14(3):553-63. doi: 10.1111/j.1582-4934.2009.00903.x. Epub 2009 Sep 14. Review.


Delayed treatments for stroke influence neuronal death in rat organotypic slice cultures subjected to oxygen glucose deprivation.

Hall AA, Leonardo CC, Collier LA, Rowe DD, Willing AE, Pennypacker KR.

Neuroscience. 2009 Dec 1;164(2):470-7. doi: 10.1016/j.neuroscience.2009.08.051. Epub 2009 Aug 29.


Human umbilical cord blood cell grafts for brain ischemia.

Park DH, Borlongan CV, Willing AE, Eve DJ, Cruz LE, Sanberg CD, Chung YG, Sanberg PR.

Cell Transplant. 2009;18(9):985-98. doi: 10.3727/096368909X471279. Epub 2009 Apr 29. Review.


Umbilical cord blood cells.

Newcomb JD, Willing AE, Sanberg PR.

Methods Mol Biol. 2009;549:119-36. doi: 10.1007/978-1-60327-931-4_9.


Blockade of adrenoreceptors inhibits the splenic response to stroke.

Ajmo CT Jr, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA, Cuevas J, Willing AE, Pennypacker KR.

Exp Neurol. 2009 Jul;218(1):47-55. doi: 10.1016/j.expneurol.2009.03.044. Epub 2009 Apr 14.


Human health risk assessment of long chain alcohols.

Veenstra G, Webb C, Sanderson H, Belanger SE, Fisk P, Nielsen A, Kasai Y, Willing A, Dyer S, Penney D, Certa H, Stanton K, Sedlak R.

Ecotoxicol Environ Saf. 2009 May;72(4):1016-30. doi: 10.1016/j.ecoenv.2008.07.012. Epub 2009 Feb 23. Review.


Age-dependent response of the acid-base parameters (Henderson-Hasselbalch, Stewart) in healthy calves with experimentally induced metabolic acidosis.

Elkhair NM, Siegling-Vlitakis C, Radtke E, Willing A, Hartmann H.

Berl Munch Tierarztl Wochenschr. 2009 Jan-Feb;122(1-2):63-9.


Environmental properties of long-chain alcohols. Part 2: Structure-activity relationship for chronic aquatic toxicity of long-chain alcohols.

Schäfers C, Boshof U, Jürling H, Belanger SE, Sanderson H, Dyer SD, Nielsen AM, Willing A, Gamon K, Kasai Y, Eadsforth CV, Fisk PR, Girling AE.

Ecotoxicol Environ Saf. 2009 May;72(4):996-1005. doi: 10.1016/j.ecoenv.2008.07.019. Epub 2009 Jan 19.


Experimental models: help or hindrance.

Willing AE.

Stroke. 2009 Mar;40(3 Suppl):S152-4. doi: 10.1161/STROKEAHA.108.533505. Epub 2008 Dec 8.


An overview of hazard and risk assessment of the OECD high production volume chemical category--long chain alcohols [C(6)-C(22)] (LCOH).

Sanderson H, Belanger SE, Fisk PR, Schäfers C, Veenstra G, Nielsen AM, Kasai Y, Willing A, Dyer SD, Stanton K, Sedlak R.

Ecotoxicol Environ Saf. 2009 May;72(4):973-9. doi: 10.1016/j.ecoenv.2008.10.006. Epub 2008 Nov 26.


Environmental properties of long chain alcohols. Part 1: Physicochemical, environmental fate and acute aquatic toxicity properties.

Fisk PR, Wildey RJ, Girling AE, Sanderson H, Belanger SE, Veenstra G, Nielsen A, Kasai Y, Willing A, Dyer SD, Stanton K.

Ecotoxicol Environ Saf. 2009 May;72(4):980-95. doi: 10.1016/j.ecoenv.2008.09.025. Epub 2008 Nov 26. Review.


Assessment of the environmental risk of long-chain aliphatic alcohols.

Belanger SE, Sanderson H, Fisk PR, Schäfers C, Mudge SM, Willing A, Kasai Y, Nielsen AM, Dyer SD, Toy R.

Ecotoxicol Environ Saf. 2009 May;72(4):1006-15. doi: 10.1016/j.ecoenv.2008.07.013. Epub 2008 Nov 14.


Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death.

Hall AA, Guyer AG, Leonardo CC, Ajmo CT Jr, Collier LA, Willing AE, Pennypacker KR.

J Neurosci Res. 2009 Feb;87(2):333-41. doi: 10.1002/jnr.21857.


sigma-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons.

Herrera Y, Katnik C, Rodriguez JD, Hall AA, Willing A, Pennypacker KR, Cuevas J.

J Pharmacol Exp Ther. 2008 Nov;327(2):491-502. doi: 10.1124/jpet.108.143974. Epub 2008 Aug 22.


Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose.

Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, Miller C, Rossi R, Sanberg PR.

PLoS One. 2008 Jun 25;3(6):e2494. doi: 10.1371/journal.pone.0002494.

Supplemental Content

Loading ...
Support Center